Atlas Trials

Ketamine and Levetiracetam as Second-line Antiseizure Medication for Status Epilepticus in Children

Clinical trial NCT07046611 · RECRUITING

Trial details

NCT number
NCT07046611
Sponsor
Sohag University
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Generalized Convulsive Status Epilepticus
Start date
2025-07-02
Primary completion
2026-06-30
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.